Join
Live feed
·
INSIDERFilingvia Quantisnow
MyMD Pharmaceuticals Inc. logo

SEC Form 4: Rivard Paul bought $28,080 worth of shares (25,000 units at $1.12), increasing direct ownership by 11% to 250,000 units

ByQuantisnow·Wall Street's wire, on your screen.
MYMD· MyMD Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MYMD (MyMD Pharmaceuticals Inc.) and more on Quantisnow.